Commonwealth Fusion Systems (CFS), the leading fusion power startup, has raised $4 billion over seven years, including a recent $1 billion round. The company’s current momentum and recent leadership change suggest it could go public within two to three years. Notably, CFS appointed Lorence Kim as its new chief financial officer. Kim previously helped take biotech firm Moderna public in 2018, and he compares fusion’s current stage to where mRNA was a decade ago—scientifically validated but not yet commercially proven.

Kim’s background, although rooted in biotech, aligns with CFS’s mission, which combines cutting-edge science with a pressing global urgency. CFS emphasizes that his hiring does not immediately indicate IPO preparations, as Moderna took several years from his arrival to go public. However, given the steady progress on CFS’s Sparc demonstration reactor and its commercial ambitions, industry observers expect a public offering sooner rather than later.

CFS aims to operate Sparc by late 2026, with a goal of achieving scientific breakeven in 2027—when fusion output exceeds input energy. This milestone is critical, as only one previous experiment has achieved it, and it would demonstrate progress toward viable fusion power. Concurrently, CFS has begun developing Arc, its first commercial-scale fusion plant, with a site chosen in Chesterfield County, Virginia, and permits underway to bring it online in the early 2030s.

While CFS still faces years of high expenditures, hiring Kim positions the company to navigate public markets effectively. The fusion sector is heating up with other companies like General Fusion and TAE Technologies becoming publicly traded recently. With tech firms eager for green energy and fusion poised as a potential clean power solution, CFS is likely to capitalize on favorable investor interest before this opportunity wanes.